Stock data
10x Genomics, Inc. (TXG)
10x Genomics, Inc. (TXG) reported revenue of US$642.82M and net income of -US$43.54M for fiscal 2025. The figures below come from the company's SEC filings.
Annual results
Data as of 2025-12-31
| Fiscal year | Revenue | Gross profit | Operating income | Net income | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | US$642.82M | US$443.88M | -US$60.98M | -US$43.54M | — |
| 2024 | US$610.78M | US$414.48M | -US$194.56M | -US$182.63M | — |
| 2023 | US$618.73M | US$409.31M | -US$265.33M | -US$255.10M | — |
| 2022 | US$516.41M | US$396.02M | -US$167.94M | -US$166.00M | — |
| 2021 | US$490.49M | US$416.40M | -US$52.25M | -US$58.22M | — |
Quarterly results
Data as of 2026-06-30
| Quarter | Revenue | Net income | Diluted EPS |
|---|---|---|---|
| 2026-06-30 | US$151.04M | -US$17.93M | — |
| 2026-03-31 | US$150.84M | -US$13.47M | — |
| 2025-12-31 | US$166.03M | -US$16.25M | — |
| 2025-09-30 | US$149.00M | -US$27.47M | — |
| 2025-06-30 | US$172.91M | US$34.54M | — |
| 2025-03-31 | US$154.88M | -US$34.36M | — |
| 2024-12-31 | US$165.02M | -US$49.03M | — |
| 2024-09-30 | US$151.65M | -US$35.75M | — |
Sources
- Source: SEC EDGAR company facts
Charts, drawing tools, and the P/E calculator are in the app, free to use.